Abstract:Motivation: Identifying and developing novel therapeutic effects for existing drugs contributes to reduction of drug development costs. Most of the previous methods focus on integration of the heterogeneous data of drugs and diseases from multiple sources for predicting the candidate drug-disease associations. However, they fail to take the prior knowledge of drugs and diseases and their sparse characteristic into account. It is essential to develop a method that exploits the more useful information to predict the reliable candidate associations. Results: We present a method based on non-negative matrix factorization, DisDrugPred, to predict the drug-related candidate disease indications. A new type of drug similarity is firstly calculated based on their associated diseases. DisDrugPred completely integrates two types of disease similarities, the associations between drugs and diseases, and the various similarities between drugs from different levels including the chemical structures of drugs, the target proteins of drugs, the diseases associated with drugs and the side effects of drugs. The prior knowledge of drugs and diseases and the sparse characteristic of drug-disease associations provide a deep biological perspective for capturing the relationships between drugs and diseases. Simultaneously, the possibility that a drug is associated with a disease is also dependant on their projections in the low-dimension feature space. Therefore, DisDrugPred deeply integrates the diverse prior knowledge, the sparse characteristic of associations and the projections of drugs and diseases. DisDrugPred achieves superior prediction performance than several state-of-the-art methods for drug-disease association prediction. During the validation process, DisDrugPred also can retrieve more actual drug-disease associations in the top part of prediction result which often attracts more attention from the biologists. Moreover, case studies on five drugs further confirm DisDrugPred's ability to discover potential candidate disease indications for drugs.

LRSSL: predict and interpret drug-disease associations based on data integration using sparse subspace learning.

Exploring the associations between drug side-effects and therapeutic indications.

Drug Side Effect Prediction Through Linear Neighborhoods and Multiple Data Source Integration

Learning from low-rank multimodal representations for predicting disease-drug associations

SFLLN: A Sparse Feature Learning Ensemble Method with Linear Neighborhood Regularization for Predicting Drug–drug Interactions

Link Prediction Only with Interaction Data and Its Application on Drug Repositioning

De Novo Prediction of Drug-Target Interactions Using Laplacian Regularized Schatten P-Norm Minimization.

De novo Prediction of Drug-Target Interaction via Laplacian Regularized Schatten-p Norm Minimization

Predicting drug-disease associations by using similarity constrained matrix factorization

Drug Repositioning Through Integration of Prior Knowledge and Projections of Drugs and Diseases

Multi-level Subgraph Representation Learning for Drug-Disease Association Prediction over Heterogeneous Biological Information Network.

Predicting Associations among Drugs, Targets and Diseases by Tensor Decomposition for Drug Repositioning

DrugSK: A Stacked Ensemble Learning Framework for Predicting Drug Combinations of Multiple Diseases

Drug-disease association prediction using semantic graph and function similarity representation learning over heterogeneous information networks

Predicting Drug-Target Interactions Via Sparse Learning.

Prediction of Drug-Disease Associations and Their Effects by Signed Network-Based Nonnegative Matrix Factorization

Neighborhood Regularized Logistic Matrix Factorization for Drug-Target Interaction Prediction

Drug-disease association prediction with literature based multi-feature fusion

Identification of Drug–Target Interactions via Dual Laplacian Regularized Least Squares with Multiple Kernel Fusion

Identification of drug-side effect association via multiple information integration with centered kernel alignment

SDLDA: lncRNA-disease association prediction based on singular value decomposition and deep learning